CE Holdings Co.,Ltd. Fiscal Year Ending September 2026 Financial Summary (Japan GAAP) (Consolidated)

Overview of Results

For the fiscal year ending September 2026, consolidated net sales were 16,173 million yen, achieving a 2.2% increase year-on-year. Operating income was 1,447 million yen, up 2.6% year-on-year, and ordinary income was 1,481 million yen, up 3.9%. Meanwhile, net income attributable to owners of parent decreased significantly to 756 million yen year-on-year. The primary reasons were the absence of special gains related to Micron compared with the prior year and impairments related to Doctor Connect. Orders received totaled 13,997 million yen and order backlog was 4,152 million yen, both showing a declining trend.

Outlook and Key Developments

While the majority of operations depend on the medical information systems sector, long-term growth potential exists due to government-led medical DX initiatives and broader adoption of electronic medical records. However, the company's shares are undergoing procedures for delisting and share consolidation, and no earnings guidance for the fiscal year ending September 2027 or later has been published. Notes on the financial condition using supplementary materials were provided; future cash flow trends and capital policy will be key factors for investment decisions.